Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Healthcare Services. Per the activity note to the FY2024 annual report, the company operates as a clinical research organization conducting trials and studies globally.
Subsidiary of Shezghuduli Pasukhismgeblobis Sazogadoeba Pareksel International Holding Bi.vi. (100.0%)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 1,059 | 773 | 2,275 | 546 | 0 | 0 | nmf |
| Net Cash used in Investing Activities | 47 | 0 | 214 | 183 | 0 | 0 | +57.0% |
| Free Cash Flow (OCF − Capex proxy) | 1,012 | 773 | 2,061 | 729 | 0 | 0 | nmf |
| Net Change in Cash (before FX) | 1,012 | 773 | 2,061 | 729 | 0 | 0 | nmf |
| Effect of FX on Cash | 3 | 597 | 189 | 341 | 0 | 0 | nmf |
| Net Change in Cash (incl. FX) | 1,009 | 176 | 1,872 | 1,070 | 0 | 0 | nmf |
| Cash at Beginning of Year | 230 | 1,239 | 1,063 | 2,935 | 1,865 | 2,537 | +61.7% |
| Cash at End of Year | 1,239 | 1,063 | 2,935 | 1,865 | 1,865 | 2,537 | +15.4% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →